Khan et al., 2017 - Google Patents
Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptidesKhan et al., 2017
- Document ID
- 2183245253895568367
- Author
- Khan F
- Ulanova M
- Bai B
- Yalamati D
- Jiang Z
- Publication year
- Publication venue
- European Journal of Medicinal Chemistry
External Links
Snippet
Muramyl dipeptide (MDP)–an essential bacterial cell wall component–is recognized by our immune system as pathogen-associated molecular pattern (PAMP) which results in immune responses with adverse toxic effects. In order to harness the beneficial properties from the …
- 102000004196 processed proteins & peptides 0 title abstract description 18
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Khan et al. | Design, synthesis and immunological evaluation of novel amphiphilic desmuramyl peptides | |
| KR102235870B1 (en) | Conjugate compounds | |
| CN108250159B (en) | Urea compound, preparation method and application thereof | |
| DK3041827T3 (en) | 1,2,4-OXADIAZOLD DERIVATIVES AS IMMUNE MODULATORS | |
| JP5419685B2 (en) | IAPBIR domain binding protein | |
| US6399568B1 (en) | Cyclic tetrapeptide derivatives and medicinal use thereof | |
| WO2015106599A1 (en) | Conjugates and compositions for drug delivery | |
| WO2015036927A1 (en) | Immunomodulating peptidomimetic derivatives | |
| EP3366289A1 (en) | Cyclic peptidomimetic compounds as immunomodulators | |
| JP2009512719A (en) | IAPBIR domain binding compound | |
| AU602483B2 (en) | Immunoregulatory peptides | |
| JP2001527065A (en) | Γ-glutamyl and β-aspartyl containing immunomodulatory compounds and methods using the same | |
| Jakopin et al. | Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1) | |
| Guzelj et al. | Structural fine-tuning of desmuramylpeptide NOD2 agonists defines their in vivo adjuvant activity | |
| AU2017246706A1 (en) | Neuropeptide s receptor (NPSR) agonists | |
| CA3104674A1 (en) | Natural killer cells | |
| Du et al. | Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam3CSK4 | |
| WO1994002445A1 (en) | Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression | |
| JP2023508446A (en) | Cyclic peptide receptor lanthionine synthetase C-like protein (LANCL) and uses thereof | |
| CA2133569A1 (en) | Novel lipophilic oligopeptides with immunomodulating activity | |
| Yang et al. | Next-generation diprovocims with potent human and murine TLR1/TLR2 agonist activity that activate the innate and adaptive immune response | |
| JPH11507620A (en) | Synthetic peptides and pharmaceutical compositions containing them | |
| KR20070012524A (en) | Cyclopeptide Derivatives Having Integrin Inhibitory Activity | |
| NL9000551A (en) | SDK PEPTIDES, METHOD FOR THE PREPARATION THEREOF, AND THERAPEUTIC PREPARATIONS CONTAINING THEM. | |
| WO2022054625A1 (en) | Pyrrole-imidazole polyamide having improved nuclear transportation properties |